IL211552A0 - Improved antibody libraries - Google Patents
Improved antibody librariesInfo
- Publication number
- IL211552A0 IL211552A0 IL211552A IL21155211A IL211552A0 IL 211552 A0 IL211552 A0 IL 211552A0 IL 211552 A IL211552 A IL 211552A IL 21155211 A IL21155211 A IL 21155211A IL 211552 A0 IL211552 A0 IL 211552A0
- Authority
- IL
- Israel
- Prior art keywords
- antibody libraries
- improved antibody
- improved
- libraries
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B50/00—Methods of creating libraries, e.g. combinatorial synthesis
- C40B50/06—Biochemical methods, e.g. using enzymes or whole viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/185—Nucleic acid dedicated to use as a hidden marker/bar code, e.g. inclusion of nucleic acids to mark art objects or animals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10148308P | 2008-09-30 | 2008-09-30 | |
| PCT/US2009/059059 WO2010039852A2 (en) | 2008-09-30 | 2009-09-30 | Improved antibody libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL211552A0 true IL211552A0 (en) | 2011-05-31 |
Family
ID=42074188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL211552A IL211552A0 (en) | 2008-09-30 | 2011-03-03 | Improved antibody libraries |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8404445B2 (enExample) |
| EP (1) | EP2340256A4 (enExample) |
| JP (1) | JP2012504416A (enExample) |
| KR (1) | KR20110061629A (enExample) |
| CN (1) | CN102227440A (enExample) |
| AU (1) | AU2009298501A1 (enExample) |
| CA (1) | CA2736430A1 (enExample) |
| IL (1) | IL211552A0 (enExample) |
| MX (1) | MX2011003380A (enExample) |
| NZ (1) | NZ591543A (enExample) |
| RU (1) | RU2011117213A (enExample) |
| TW (1) | TW201028432A (enExample) |
| WO (1) | WO2010039852A2 (enExample) |
| ZA (1) | ZA201102119B (enExample) |
Families Citing this family (78)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4986370B2 (ja) | 2000-12-22 | 2012-07-25 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | Ｒｇｍおよびそのモジュレーターの用途 |
| EP1928905B1 (de) * | 2005-09-30 | 2015-04-15 | AbbVie Deutschland GmbH & Co KG | Bindungsdomänen von proteinen der repulsive guidance molecule (rgm) proteinfamilie und funktionale fragmente davon sowie deren verwendung |
| EP2033971A1 (de) * | 2007-09-06 | 2009-03-11 | Abbott GmbH & Co. KG | Bone Morphogenetic Protein (BMP)-bindende Domänen von Proteinen der Repulsive Guidance Molecule (RGM) Proteinfamilie und funktionale Fragmente davon sowie deren Verwendung |
| US8962803B2 (en) * | 2008-02-29 | 2015-02-24 | AbbVie Deutschland GmbH & Co. KG | Antibodies against the RGM A protein and uses thereof |
| PE20160653A1 (es) | 2009-03-05 | 2016-07-24 | Abbvie Inc | Proteinas de union a il-17 |
| US9085798B2 (en) | 2009-04-30 | 2015-07-21 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
| PE20121647A1 (es) | 2009-08-29 | 2012-12-31 | Abbvie Inc | Proteinas terapeuticas de union a dll4 |
| KR20120118002A (ko) * | 2009-12-08 | 2012-10-25 | 애보트 게엠베하 운트 콤파니 카게 | 망막 신경 섬유 층 변성의 치료에 사용하기 위한 ｒｇｍ ａ 단백질에 대한 모노클로날 항체 |
| SG10201501562VA (en) | 2010-03-02 | 2015-04-29 | Abbvie Inc | Therapeutic dll4 binding proteins |
| US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
| US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
| PT2556171E (pt) | 2010-04-05 | 2015-12-21 | Prognosys Biosciences Inc | Ensaios biológicos codificados espacialmente |
| EP2571532B1 (en) | 2010-05-14 | 2017-05-03 | Abbvie Inc. | Il-1 binding proteins |
| EP3150750B1 (en) | 2011-04-08 | 2018-12-26 | Prognosys Biosciences, Inc. | Peptide constructs and assay systems |
| GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
| EP3421591B1 (en) * | 2011-04-28 | 2023-09-27 | The Board of Trustees of the Leland Stanford Junior University | Identification of polynucleotides associated with a sample |
| US20230287392A1 (en) * | 2011-04-28 | 2023-09-14 | The Board Of Trustees Of The Leland Stanford Junior University | Identification of Polynucleotides Associated with a Sample |
| WO2012158739A1 (en) | 2011-05-17 | 2012-11-22 | Bristol-Myers Squibb Company | Improved methods for the selection of binding proteins |
| KR102139388B1 (ko) | 2011-07-12 | 2020-07-30 | 엑스바이오테크, 인크. | 친화성 성숙 인간 항체의 동정 |
| JP2014527801A (ja) | 2011-09-01 | 2014-10-23 | ユニバーシティ オブ サザン カリフォルニア | ハイスループットペプチドミメティックを調製するための方法、経口バイオアベイラブルな薬物およびそれを含有する組成物 |
| PE20190907A1 (es) | 2012-01-27 | 2019-06-26 | AbbVie Deutschland GmbH and Co KG | Composicion y metodo para el diagnostico y el tratamiento de las enfermedades asociadas a la degeneracion de las neuritas |
| WO2014011955A2 (en) | 2012-07-12 | 2014-01-16 | Abbvie, Inc. | Il-1 binding proteins |
| UA118441C2 (uk) | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Антитіло, що розпізнає альфа-синуклеїн |
| DK3511423T4 (da) | 2012-10-17 | 2024-07-29 | Spatial Transcriptomics Ab | Fremgangsmåder og produkt til optimering af lokaliseret eller rumlig detektion af genekspression i en vævsprøve |
| US10119134B2 (en) | 2013-03-15 | 2018-11-06 | Abvitro Llc | Single cell bar-coding for antibody discovery |
| HK1221013A1 (zh) | 2013-03-15 | 2017-05-19 | 普罗格诺西斯生物科学公司 | 用於检测肽/mhc/tcr结合的方法 |
| EP4234716A3 (en) | 2013-06-25 | 2023-12-06 | Prognosys Biosciences, Inc. | Methods for determining spatial patterns of biological targets in a sample |
| US9951131B2 (en) | 2013-07-12 | 2018-04-24 | Prothena Biosciences Limited | Antibodies that recognize IAPP |
| US9850302B2 (en) | 2013-07-12 | 2017-12-26 | Prothena Biosciences Limited | Antibodies that recognize IAPP |
| US9409139B2 (en) | 2013-08-05 | 2016-08-09 | Twist Bioscience Corporation | De novo synthesized gene libraries |
| WO2015070037A2 (en) | 2013-11-08 | 2015-05-14 | Prognosys Biosciences, Inc. | Polynucleotide conjugates and methods for analyte detection |
| AU2014375402B2 (en) * | 2013-12-30 | 2020-10-01 | CureVac SE | Artificial nucleic acid molecules |
| WO2015155694A1 (en) | 2014-04-08 | 2015-10-15 | Prothena Biosciences Limited | Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein |
| SG10201911069WA (en) | 2014-09-15 | 2020-01-30 | Abvitro Llc | High-throughput nucleotide library sequencing |
| JP6897952B2 (ja) * | 2014-09-16 | 2021-07-07 | 国立大学法人東京海洋大学 | 濃縮された生着能をもつ未分化生殖細胞を用いた生殖細胞系列への分化誘導方法 |
| KR101694832B1 (ko) * | 2014-12-31 | 2017-01-12 | 앱클론(주) | 항체 라이브러리 및 그의 제작방법 |
| WO2016114567A1 (ko) * | 2015-01-13 | 2016-07-21 | 이화여자대학교 산학협력단 | 신규 항체 라이브러리 제조방법 및 이로부터 제조된 라이브러리 |
| US20160222377A1 (en) * | 2015-01-29 | 2016-08-04 | Terry T. Takahashi | Method for generating ultra high affinity peptide ligands |
| CA2975852A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| WO2016160844A2 (en) * | 2015-03-30 | 2016-10-06 | Cellular Research, Inc. | Methods and compositions for combinatorial barcoding |
| EP4119677B1 (en) | 2015-04-10 | 2023-06-28 | Spatial Transcriptomics AB | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
| WO2016172377A1 (en) | 2015-04-21 | 2016-10-27 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| ES2743448T3 (es) * | 2015-04-23 | 2020-02-19 | Hoffmann La Roche | Procedimiento y composición del polipéptido de andamio de anticuerpo de vaca |
| AU2016324296A1 (en) | 2015-09-18 | 2018-04-12 | Twist Bioscience Corporation | Oligonucleic acid variant libraries and synthesis thereof |
| CN108698012A (zh) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | 用于核酸合成的柔性基底 |
| CN108603307A (zh) | 2015-12-01 | 2018-09-28 | 特韦斯特生物科学公司 | 功能化表面及其制备 |
| JP7086856B2 (ja) * | 2016-04-12 | 2022-06-20 | メディミューン，エルエルシー | 免疫レパートリー発掘 |
| US12048718B2 (en) | 2016-06-07 | 2024-07-30 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Geminschaft | Chimeric antigen receptor and CAR-T cells that bind BCMA |
| WO2018005720A1 (en) * | 2016-06-30 | 2018-01-04 | President And Fellows Of Harvard College | Method of determining the molecular binding between libraries of molecules |
| CA3034769A1 (en) | 2016-08-22 | 2018-03-01 | Twist Bioscience Corporation | De novo synthesized nucleic acid libraries |
| US10858649B2 (en) | 2016-09-15 | 2020-12-08 | Augmenta Bioworks, Inc. | Immune repertoire sequence amplification methods and applications |
| CN110248724B (zh) | 2016-09-21 | 2022-11-18 | 特韦斯特生物科学公司 | 基于核酸的数据存储 |
| CN110366613A (zh) | 2016-12-16 | 2019-10-22 | 特韦斯特生物科学公司 | 免疫突触的变体文库及其合成 |
| WO2018156792A1 (en) | 2017-02-22 | 2018-08-30 | Twist Bioscience Corporation | Nucleic acid based data storage |
| CN110913865A (zh) | 2017-03-15 | 2020-03-24 | 特韦斯特生物科学公司 | 免疫突触的变体文库及其合成 |
| IL271205B2 (en) | 2017-06-12 | 2025-02-01 | Twist Bioscience Corp | Methods for assembling continuous nucleic acids |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| US11407837B2 (en) | 2017-09-11 | 2022-08-09 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
| KR102637566B1 (ko) | 2017-10-20 | 2024-02-16 | 트위스트 바이오사이언스 코포레이션 | 폴리뉴클레오타이드 합성을 위한 가열된 나노웰 |
| KR102875544B1 (ko) * | 2017-11-20 | 2025-10-23 | 난트바이오 인코포레이티드 | mRNA 디스플레이 항체 라이브러리 및 방법 |
| CN112041438B (zh) | 2018-01-04 | 2025-05-23 | 特韦斯特生物科学公司 | 基于dna的数字信息存储 |
| US20210139985A1 (en) * | 2018-04-10 | 2021-05-13 | Board Of Regents, The University Of Texas System | Dna-barcoded antigen multimers and methods of use thereof |
| CA3100739A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| US11662341B2 (en) | 2018-10-10 | 2023-05-30 | Augmenta Bioworks, Inc. | Methods for isolating immune binding proteins |
| CA3124980A1 (en) | 2018-12-26 | 2020-07-02 | Twist Bioscience Corporation | Highly accurate de novo polynucleotide synthesis |
| CN113785057A (zh) | 2019-02-26 | 2021-12-10 | 特韦斯特生物科学公司 | 用于抗体优化的变异核酸文库 |
| KR20210143766A (ko) | 2019-02-26 | 2021-11-29 | 트위스트 바이오사이언스 코포레이션 | Glp1 수용체에 대한 변이체 핵산 라이브러리 |
| WO2020205426A1 (en) * | 2019-03-29 | 2020-10-08 | The Regents Of The University Of California | Comprehensive identification of interacting protein targets using mrna display of uniform libraries |
| JP2022550497A (ja) | 2019-06-21 | 2022-12-02 | ツイスト バイオサイエンス コーポレーション | バーコードに基づいた核酸配列アセンブリ |
| CA3155629A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for crth2 |
| AU2020355027A1 (en) | 2019-09-23 | 2022-04-21 | Twist Bioscience Corporation | Antibodies that bind CD3 Epsilon |
| CA3177029A1 (en) | 2020-04-27 | 2021-11-04 | Aaron Sato | Variant nucleic acid libraries for coronavirus |
| US12391762B2 (en) | 2020-08-26 | 2025-08-19 | Twist Bioscience Corporation | Methods and compositions relating to GLP1R variants |
| US11970697B2 (en) | 2020-10-19 | 2024-04-30 | Twist Bioscience Corporation | Methods of synthesizing oligonucleotides using tethered nucleotides |
| EP4281112A4 (en) | 2021-01-21 | 2025-01-15 | Twist Bioscience Corporation | METHODS AND COMPOSITIONS RELATING TO ADENOSINE RECEPTORS |
| US12258406B2 (en) | 2021-03-24 | 2025-03-25 | Twist Bioscience Corporation | Antibodies that bind CD3 Epsilon |
| WO2022271884A2 (en) | 2021-06-22 | 2022-12-29 | Twist Bioscience Corporation | Methods and compositions relating to covid antibody epitopes |
| WO2023130123A2 (en) | 2022-01-03 | 2023-07-06 | Twist Bioscience Corporation | Bispecific sars-cov-2 antibodies and methods of use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT971946E (pt) * | 1997-01-21 | 2006-11-30 | Gen Hospital Corp | Selecção de proteínas utilizando fusões arn-proteína |
| CA2323638A1 (en) * | 1998-04-03 | 1999-10-14 | Phylos, Inc. | Addressable protein arrays |
| CA2670471A1 (en) | 2006-11-22 | 2008-06-05 | Adnexus, A Bristol-Myers Squibb R&D Company (A Delaware Corporation) | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| NZ587766A (en) * | 2008-03-03 | 2013-06-28 | Abbott Lab | Methods for transforming yeast |
-
2009
- 2009-09-30 US US12/570,897 patent/US8404445B2/en not_active Expired - Fee Related
- 2009-09-30 WO PCT/US2009/059059 patent/WO2010039852A2/en not_active Ceased
- 2009-09-30 CA CA2736430A patent/CA2736430A1/en not_active Abandoned
- 2009-09-30 TW TW098133249A patent/TW201028432A/zh unknown
- 2009-09-30 KR KR1020117009192A patent/KR20110061629A/ko not_active Withdrawn
- 2009-09-30 RU RU2011117213/10A patent/RU2011117213A/ru not_active Application Discontinuation
- 2009-09-30 NZ NZ591543A patent/NZ591543A/xx not_active IP Right Cessation
- 2009-09-30 CN CN2009801477246A patent/CN102227440A/zh active Pending
- 2009-09-30 JP JP2011530180A patent/JP2012504416A/ja active Pending
- 2009-09-30 MX MX2011003380A patent/MX2011003380A/es active IP Right Grant
- 2009-09-30 EP EP09818451A patent/EP2340256A4/en not_active Withdrawn
- 2009-09-30 AU AU2009298501A patent/AU2009298501A1/en not_active Abandoned
-
2011
- 2011-03-03 IL IL211552A patent/IL211552A0/en unknown
- 2011-03-22 ZA ZA2011/02119A patent/ZA201102119B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8404445B2 (en) | 2013-03-26 |
| WO2010039852A2 (en) | 2010-04-08 |
| WO2010039852A3 (en) | 2010-07-29 |
| TW201028432A (en) | 2010-08-01 |
| KR20110061629A (ko) | 2011-06-09 |
| ZA201102119B (en) | 2011-12-28 |
| JP2012504416A (ja) | 2012-02-23 |
| CA2736430A1 (en) | 2010-04-08 |
| MX2011003380A (es) | 2011-04-21 |
| EP2340256A4 (en) | 2012-03-21 |
| AU2009298501A1 (en) | 2010-04-08 |
| US20100099103A1 (en) | 2010-04-22 |
| CN102227440A (zh) | 2011-10-26 |
| RU2011117213A (ru) | 2012-11-10 |
| NZ591543A (en) | 2012-11-30 |
| EP2340256A2 (en) | 2011-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL211552A0 (en) | Improved antibody libraries | |
| EP2241578A4 (en) | ANTI-CLDN6 ANTIBODIES | |
| IL211850A0 (en) | Improved antibody molecules | |
| GB0821100D0 (en) | Antibodies | |
| SI2146745T1 (sl) | Penta-specifično protitelo | |
| EP2138576A4 (en) | ANTI-CLAUDIN-4 ANTIBODY | |
| SG10201601279SA (en) | Monoclonal Antibody STRO-4 | |
| GB0708002D0 (en) | Antibodies | |
| EP2331579A4 (en) | MONOCLONAL ANTIBODIES | |
| PT2374883T (pt) | Anticorpo anti-cd4 | |
| ZA201005348B (en) | Humanized anti-c5ar antibodies | |
| IL204537A0 (en) | Modified antibody constant region | |
| IL210903A0 (en) | Anit-il-12/il-23 antibodies | |
| IL208869A0 (en) | Anti-cxcr4 antibodies | |
| SI2200700T1 (sl) | Nova protitelesa | |
| ZA201006099B (en) | Anti-tyrp1 antibodies | |
| IL205073A0 (en) | Anti-bst2 antibody | |
| GB0718737D0 (en) | Antibodies | |
| GB0702888D0 (en) | Novel Antibodies | |
| ZA201007976B (en) | Anti-pirb antibodies | |
| IL212900A0 (en) | Isoform specific anti-her4 antibodies | |
| GB0818356D0 (en) | Antibodies | |
| EP2304439A4 (en) | ANTI-phospho-AKT ANTIBODY | |
| GB0911770D0 (en) | Antibody | |
| EP2264071A4 (en) | ANTIBODY WITH AN IMMUNE-REINFORCING FUNCTION |